About Mercury Laboratories
Mercury Laboratories is a company based in Vadodara (India) founded in 1962. The company has 503 employees. Mercury Laboratories offers products and services including Pharmaceuticals and Export Products.
- Headquarter Vadodara, India
- Employees 503
- Stage Public
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website mercurylabs.com
- Social LinkedIn Facebook
- Legal Name Mercury Laboratories Ltd.
- Annual Revenue₹76.17 Cr
FY 2025 · -1% YoY
- Net Profit₹3.14 Cr
FY 2025 · 4% margin
- EBITDA₹7.02 Cr
FY 2025 · 9% margin
- Employee Count503
Associated legal entities of Mercury Laboratories
Mercury Laboratories operates through Mercury Laboratories Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Mercury Laboratories Limited Listed CIN L74239MH1982PLC026341 | Active | 12 Feb 1982 | Mumbai, Maharashtra | ₹76.2 Cr | 471 | 8 | View details |
Products & Services of Mercury Laboratories
Mercury Laboratories offers a comprehensive portfolio of products and services, including Pharmaceuticals and Export Products.
Safe and innovative pharmaceuticals are formulated and distributed to improve patient quality of life
Pharmaceutical products are marketed and distributed globally for various health needs
Board of directors of Mercury Laboratories Limited (Mercury Laboratories)
Mercury Laboratories Limited is the primary company behind Mercury Laboratories. The board of Mercury Laboratories Limited currently have 6 directors; the longest-serving is Rajendrakumar Ramanlal Shah, appointed in 1982. 14 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rajendrakumar Ramanlal Shah DIN 00257253 | Managing Director | 16 Feb 1982 | 44 yrs 7 mo | Mercury Laboratories Limited |
| Dilip Ramanlal Shah DIN 00257242 | Director | 16 Feb 1982 | 44 yrs 7 mo | Mercury Laboratories Limited |
| Paresh Jagdishbhai Mistry DIN 07893654 | Director | 01 Oct 2017 | 9 yrs | Mercury Laboratories Limited |
| Janki Rajendra Shah DIN 08686344 | Director | 05 Feb 2020 | 6 yrs 8 mo | Mercury Laboratories Limited |
| Jayantilal Dhaneshwar Raval DIN 10662609 | Director | 24 Jul 2024 | 2 yrs 2 mo | Mercury Laboratories Limited |
| Sanjay Patel DIN 00283429 | Director | 14 May 2025 | 1 yr 4 mo | Mercury Laboratories Limited |
People of Mercury Laboratories
1 people are tracked at Mercury Laboratories (1 in leadership); the tracked headcount is 503.
| Name | Role | Group |
|---|---|---|
| Managing Director | Leadership |
Complete people profiles for Mercury Laboratories
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Mercury Laboratories
Mercury Laboratories is a publicly listed company on the BSE with ticker symbol MERCURYLAB in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date23 Feb 2015
- Listed onBSE: 538964
- Listed entityMercury Laboratories Ltd.
- Exchange sectorHealth technology
- ISININE947G01011
- Share price₹770.00 (+0.65% on the day) · 2026-10-08
- Market capitalisation₹92.4 Cr
- Price to earnings22.2
- EPS (diluted, trailing year)₹34.70
- Dividend yield0.45%
- Volume (last session)50
Financials of Mercury Laboratories
Figures of Mercury Laboratories Limited, the primary company behind Mercury Laboratories, for FY 2025. Revenue was ₹76.17 Cr (-1% year on year). Net profit was ₹3.14 Cr (4% margin). EBITDA was ₹7.02 Cr (9% margin). Revenue has grown at a compounded annual rate of +9% over three years and +6% over five years.
- ₹76.17 CrRevenue · FY 2025 · -1% YoY
- ₹3.14 CrNet profit · 4% margin
- ₹7.02 CrEBITDA · 9% margin
- ₹1.20 CrPaid-up capital
- 471Employees (provident fund records)
- +9%Revenue CAGR, 3 years
- +6%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | ₹75.9 Cr | ₹4.8 Cr | ₹8.7 Cr |
| 2024 | ₹75.1 Cr | ₹3.1 Cr | ₹7.1 Cr |
| 2023 | ₹75.6 Cr | ₹5.7 Cr | ₹9.2 Cr |
| 2022 | ₹75.3 Cr | ₹5.6 Cr | ₹8.7 Cr |
| 2021 | ₹57.9 Cr | ₹3.6 Cr | ₹7.3 Cr |
Balance sheet, profit and loss, cash flow and ratios of Mercury Laboratories Limited are on its company page.
Detailed financial statements for Mercury Laboratories
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Mercury Laboratories
The website of Mercury Laboratories (mercurylabs.com) receives about 1.1K visits a month.
- Monthly visits1.1K
▼ 11.4% vs previous month
Latest news on Mercury Laboratories
Complete news archive for Mercury Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Mercury Laboratories
10 companies that operate in the same segment as Mercury Laboratories (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Mercury Laboratories
Mercury Laboratories was founded in 1962.
Mercury Laboratories is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.
Mercury Laboratories has 503 employees.
The primary company behind Mercury Laboratories, Mercury Laboratories Limited, reported revenue of ₹76.17 Cr for FY 2025, down 1% year on year.
Mercury Laboratories was established in 1962 in Vadodara, India, within the pharmaceutical sector. Drugs are produced by the company, with operations centered on manufacturing processes. The facility is located in Vadodara, supporting regional distribution. Leadership is provided by Managing Director Rajendrakumar Ramanlal Shah, overseeing daily activities and compliance. Focus remains on standard drug production without specified additional services.
Mercury Laboratories offers Pharmaceuticals and Export Products.
Yes, Mercury Laboratories is publicly traded on BSE under the ticker symbol MERCURYLAB.
Mercury Laboratories operates through Mercury Laboratories Limited.
The legal entities of Mercury Laboratories currently have 8 directors, including Rajendrakumar Ramanlal Shah, Krishna Dhruv Shah, Ashish Girish Vasavada and others.